Avery Dennison Corp: Form 10-K for the period ended Jan 2, 2021
Filed with the SEC on Feb 25, 2021 and accepted by EDGAR at Feb 24, 2021, 19:50 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-01-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-09-27 to 2021-01-02 | $1.99bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2019-12-29 to 2021-01-02 | $6.97bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2019-12-29 to 2021-01-02 | $5.05bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-09-27 to 2021-01-02 | $571.1m | us-gaap:GrossProfit |
| Gross profit | 12 months2019-12-29 to 2021-01-02 | $1.92bn | us-gaap:GrossProfit |
| Research and development | 12 months2019-12-29 to 2021-01-02 | $112.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2019-12-29 to 2021-01-02 | $1.06bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 12 months2019-12-29 to 2021-01-02 | $70.0m | us-gaap:InterestExpense |
| Income tax | 12 months2019-12-29 to 2021-01-02 | $177.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-09-27 to 2021-01-02 | $191.5m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 12 months2019-12-29 to 2021-01-02 | $555.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-09-27 to 2021-01-02 | $2.28 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2019-12-29 to 2021-01-02 | $6.61 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-09-27 to 2021-01-02 | $2.30 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2019-12-29 to 2021-01-02 | $6.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-12-29 to 2021-01-02 | 84,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-12-29 to 2021-01-02 | $751.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-12-29 to 2021-01-02 | $201.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2019-12-29 to 2021-01-02 | $196.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2019-12-29 to 2021-01-02 | $104.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-01-02 | $252.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-01-02 | $2.42bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-01-02 | $6.08bn | us-gaap:Assets |
| Current liabilities | At period end2021-01-02 | $1.93bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2021-01-02 | $2.03bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2021-01-02 | $64.7m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2021-01-02 | $1.48bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-21-055146. Last ingested by Listed: Nov 10, 2026, 16:39 ET. Listed shows no prices and gives no investment advice.